Literature DB >> 24298852

What is the optimal means of staging colon cancer?

Elizabeth A Arena1, Anton J Bilchik.   

Abstract

Although staging for colon cancer has become more complex over time, it is not clear that this complexity has improved prognostic assessment. Even with revisions in the 7th edition of the AJCC staging system, a clear rank order of prognosis from substage to substage has not been established. Improved staging models will need to be developed, and attempts at further identifying those high-risk patients within each stage may be clinically useful. Through improved quality measures with lymph node yield, advances in colon cancer staging accuracy have been made over the last decade. Determining how to incorporate ultrastaging and molecular techniques will be the challenge for future staging models.

Entities:  

Mesh:

Year:  2013        PMID: 24298852      PMCID: PMC4657941          DOI: 10.1016/j.yasu.2013.03.001

Source DB:  PubMed          Journal:  Adv Surg        ISSN: 0065-3411


  44 in total

Review 1.  Adjuvant therapy in stage II colon cancer: current approaches.

Authors:  Lisa Baddi; Al Benson
Journal:  Oncologist       Date:  2005-05

2.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

3.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

4.  Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial.

Authors:  Nabil Wasif; Mark B Faries; Sukamal Saha; Roderick R Turner; David Wiese; Martin D McCarter; Perry Shen; Alexander Stojadinovic; Anton J Bilchik
Journal:  Surgery       Date:  2010-02-08       Impact factor: 3.982

5.  Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.

Authors:  Anton J Bilchik; Dave S B Hoon; Sukamal Saha; Roderick R Turner; David Wiese; Maggie DiNome; Kazuo Koyanagi; Martin McCarter; Perry Shen; Douglas Iddings; Steven L Chen; Maria Gonzalez; David Elashoff; Donald L Morton
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

6.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Authors:  Thierry André; Corrado Boni; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Andrea Bonetti; Philip Clingan; John Bridgewater; Fernando Rivera; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

7.  Urgent need for a new staging system in advanced colorectal cancer.

Authors:  Graeme J Poston; Joan Figueras; Felice Giuliante; Gennaro Nuzzo; Alberto F Sobrero; Jean-Francois Gigot; Bernard Nordlinger; Rene Adam; Thomas Gruenberger; Michael A Choti; Anton J Bilchik; Eric J D Van Cutsem; Jy-Ming Chiang; Michael I D'Angelica
Journal:  J Clin Oncol       Date:  2008-08-18       Impact factor: 44.544

8.  Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial.

Authors:  Andreas E Bembenek; Robert Rosenberg; Elke Wagler; Stephan Gretschel; Andreas Sendler; Joerg-Ruediger Siewert; Jörg Nährig; Helmut Witzigmann; Johann Hauss; Christian Knorr; Arno Dimmler; Jörn Gröne; Heinz-Johannes Buhr; Jörg Haier; Hermann Herbst; Juergen Tepel; Bence Siphos; Axel Kleespies; Alfred Koenigsrainer; Nikolas H Stoecklein; Olaf Horstmann; Robert Grützmann; Andreas Imdahl; Daniel Svoboda; Christian Wittekind; Wolfgang Schneider; Klaus-Dieter Wernecke; Peter M Schlag
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

9.  Lymph node ratio: role in the staging of node-positive colon cancer.

Authors:  Jiping Wang; James M Hassett; Merril T Dayton; Mahmoud N Kulaylat
Journal:  Ann Surg Oncol       Date:  2008-03-08       Impact factor: 5.344

10.  Significance of the lymph node ratio in stage III colon cancer.

Authors:  Simon H Telian; Anton J Bilchik
Journal:  Ann Surg Oncol       Date:  2008-03-25       Impact factor: 5.344

View more
  5 in total

1.  Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.

Authors:  Qi Liu; Yanlei Ma; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Int J Colorectal Dis       Date:  2018-05-16       Impact factor: 2.571

2.  Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer.

Authors:  Qi Liu; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Cancers (Basel)       Date:  2018-08-08       Impact factor: 6.639

3.  Deep Learning with Multimodal Integration for Predicting Recurrence in Patients with Non-Small Cell Lung Cancer.

Authors:  Gihyeon Kim; Sehwa Moon; Jang-Hwan Choi
Journal:  Sensors (Basel)       Date:  2022-08-31       Impact factor: 3.847

4.  P-TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management.

Authors:  Qi Liu; Dakui Luo; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  Cancer Manag Res       Date:  2018-07-31       Impact factor: 3.989

5.  SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.

Authors:  Mohd O F Sikder; Sathish Sivaprakasam; Timothy P Brown; Muthusamy Thangaraju; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Biochem J       Date:  2020-04-30       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.